Clinical Trial Update: Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) [Phase 3]

View source ↗

Summary

Phase 3 trial of infliximab for axial spondyloarthritis has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Axial Spondyloarthritis

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ankylosing Spondylitis, Axial Spondyloarthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-12-17